These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1413660)

  • 21. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo effects of prestorage filtration of apheresis platelets.
    Sweeney JD; Holme S; Stromberg RR; Heaton WA
    Transfusion; 1995 Feb; 35(2):125-30. PubMed ID: 7825207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a whole-blood WBC-reduction filter that saves platelets: in vitro studies.
    Larsson S; Gulliksson H; Paunovic D
    Transfusion; 2001 Apr; 41(4):534-9. PubMed ID: 11316906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.
    Slichter SJ; Davis K; Enright H; Braine H; Gernsheimer T; Kao KJ; Kickler T; Lee E; McFarland J; McCullough J; Rodey G; Schiffer CA; Woodson R
    Blood; 2005 May; 105(10):4106-14. PubMed ID: 15692069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
    Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
    Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technical aspects of buffy coat removal from whole blood and those of platelet production from single buffy coat units.
    Rácz Z; Baróti C
    Biomed Tech (Berl); 1993 Nov; 38(11):266-9. PubMed ID: 8123765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of platelet concentrates, prepared from pooled buffy coats, stored for 8 days after filtration.
    Boomgaard MN; Joustra-Dijkhuis AM; Gouwerok CW; Steneker I; Reesink HW; Loos JA; Pietersz RN; de Korte D
    Transfusion; 1994 Apr; 34(4):311-6. PubMed ID: 8178328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incubation of platelet concentrates before transfusion does not improve posttransfusion recovery.
    Hussein MA; Schiffer CA; Lee EJ
    Transfusion; 1990 Oct; 30(8):701-3. PubMed ID: 2219256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukocyte-depleted platelets prepared from pooled buffy coat post-transfusion increment and "in vitro bleeding time" using the Thrombostat 4000/2.
    Högman CF; Eriksson L; Kristensen J
    Transfus Sci; 1993 Jan; 14(1):35-9. PubMed ID: 10148311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
    Diedrich B; Ringdén O; Watz E; Shanwell A
    Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteria-induced release of white cell--and platelet-derived vascular endothelial growth factor in vitro.
    Nielsen HJ; Werther K; Mynster T; Svendsen MN; Rosendahl S; Elley T; Skov F
    Vox Sang; 2001 Apr; 80(3):170-8. PubMed ID: 11449957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paired comparison of platelet concentrates prepared from platelet-rich plasma and buffy coats using a new technique with 111In and 51Cr.
    Keegan T; Heaton A; Holme S; Owens M; Nelson E; Carmen R
    Transfusion; 1992 Feb; 32(2):113-20. PubMed ID: 1542917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat.
    Oksanen K; Ebeling F; Kekomäki R; Elonen E; Sahlstedt L; Volin L; Myllylä G
    Vox Sang; 1994; 67(4):356-61. PubMed ID: 7701806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic efficacy of pooled buffy-coat platelet components prepared and stored with a platelet additive solution.
    van Rhenen DJ; Gulliksson H; Cazenave JP; Pamphilon D; Davis K; Flament J; Corash L
    Transfus Med; 2004 Aug; 14(4):289-95. PubMed ID: 15285725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further studies to evaluate methods of leucoreduction to prevent alloimmune platelet refractoriness and induce tolerance in a dog platelet transfusion model.
    Slichter SJ; Abrams K; Bailey SL; Pellham E; Gettinger I; Christoffel T; Gaur L; Latchman Y; Nelson K; Bolgiano D
    Vox Sang; 2016 Jul; 111(1):62-70. PubMed ID: 27007858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
    Seghatchian J
    Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet storage lesion of WBC-reduced, pooled, buffy coat-derived platelet concentrates prepared in three in-process filter/storage bag combinations.
    Krailadsiri P; Seghatchian J; Williamson LM
    Transfusion; 2001 Feb; 41(2):243-50. PubMed ID: 11239230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.